nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—Paranoia—Carmustine—malignant glioma	0.0389	0.0547	CcSEcCtD
Fexofenadine—Otitis media—Temozolomide—malignant glioma	0.0329	0.0463	CcSEcCtD
Fexofenadine—Accidental injury—Carmustine—malignant glioma	0.03	0.0422	CcSEcCtD
Fexofenadine—Viral infection—Temozolomide—malignant glioma	0.0284	0.0399	CcSEcCtD
Fexofenadine—Dry eye—Temozolomide—malignant glioma	0.0237	0.0333	CcSEcCtD
Fexofenadine—Ear pain—Temozolomide—malignant glioma	0.0218	0.0307	CcSEcCtD
Fexofenadine—Injury—Carmustine—malignant glioma	0.021	0.0295	CcSEcCtD
Fexofenadine—Thirst—Temozolomide—malignant glioma	0.0196	0.0275	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.015	0.021	CcSEcCtD
Fexofenadine—Pollakiuria—Temozolomide—malignant glioma	0.0149	0.0209	CcSEcCtD
Fexofenadine—Sinusitis—Temozolomide—malignant glioma	0.0135	0.0189	CcSEcCtD
Fexofenadine—Flushing—Carmustine—malignant glioma	0.0124	0.0174	CcSEcCtD
Fexofenadine—Flushing—Temozolomide—malignant glioma	0.012	0.0168	CcSEcCtD
Fexofenadine—Back pain—Carmustine—malignant glioma	0.0112	0.0158	CcSEcCtD
Fexofenadine—Vision blurred—Carmustine—malignant glioma	0.0109	0.0154	CcSEcCtD
Fexofenadine—Back pain—Temozolomide—malignant glioma	0.0108	0.0152	CcSEcCtD
Fexofenadine—Agitation—Carmustine—malignant glioma	0.0107	0.015	CcSEcCtD
Fexofenadine—Vision blurred—Temozolomide—malignant glioma	0.0106	0.0149	CcSEcCtD
Fexofenadine—Agitation—Temozolomide—malignant glioma	0.0103	0.0145	CcSEcCtD
Fexofenadine—Angioedema—Temozolomide—malignant glioma	0.0102	0.0144	CcSEcCtD
Fexofenadine—Palpitations—Temozolomide—malignant glioma	0.00991	0.0139	CcSEcCtD
Fexofenadine—Myalgia—Carmustine—malignant glioma	0.00988	0.0139	CcSEcCtD
Fexofenadine—Cough—Temozolomide—malignant glioma	0.00978	0.0138	CcSEcCtD
Fexofenadine—Myalgia—Temozolomide—malignant glioma	0.00954	0.0134	CcSEcCtD
Fexofenadine—Infection—Carmustine—malignant glioma	0.00941	0.0132	CcSEcCtD
Fexofenadine—Dry mouth—Temozolomide—malignant glioma	0.00933	0.0131	CcSEcCtD
Fexofenadine—Tachycardia—Carmustine—malignant glioma	0.00924	0.013	CcSEcCtD
Fexofenadine—Anaphylactic shock—Temozolomide—malignant glioma	0.00915	0.0129	CcSEcCtD
Fexofenadine—Infection—Temozolomide—malignant glioma	0.00909	0.0128	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00863	0.0121	CcSEcCtD
Fexofenadine—Insomnia—Carmustine—malignant glioma	0.00856	0.012	CcSEcCtD
Fexofenadine—Dyspnoea—Carmustine—malignant glioma	0.00844	0.0119	CcSEcCtD
Fexofenadine—Somnolence—Carmustine—malignant glioma	0.00842	0.0118	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00834	0.0117	CcSEcCtD
Fexofenadine—Insomnia—Temozolomide—malignant glioma	0.00828	0.0116	CcSEcCtD
Fexofenadine—Dyspnoea—Temozolomide—malignant glioma	0.00816	0.0115	CcSEcCtD
Fexofenadine—Somnolence—Temozolomide—malignant glioma	0.00813	0.0114	CcSEcCtD
Fexofenadine—Pain—Carmustine—malignant glioma	0.0081	0.0114	CcSEcCtD
Fexofenadine—Dyspepsia—Temozolomide—malignant glioma	0.00805	0.0113	CcSEcCtD
Fexofenadine—Fatigue—Temozolomide—malignant glioma	0.00789	0.0111	CcSEcCtD
Fexofenadine—Loperamide—CYP2B6—malignant glioma	0.00784	0.374	CrCbGaD
Fexofenadine—Pain—Temozolomide—malignant glioma	0.00782	0.011	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Carmustine—malignant glioma	0.00774	0.0109	CcSEcCtD
Fexofenadine—Methadone—CYP2C18—malignant glioma	0.00752	0.359	CrCbGaD
Fexofenadine—Abdominal pain—Carmustine—malignant glioma	0.00748	0.0105	CcSEcCtD
Fexofenadine—Body temperature increased—Carmustine—malignant glioma	0.00748	0.0105	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00748	0.0105	CcSEcCtD
Fexofenadine—Urticaria—Temozolomide—malignant glioma	0.00727	0.0102	CcSEcCtD
Fexofenadine—Abdominal pain—Temozolomide—malignant glioma	0.00723	0.0102	CcSEcCtD
Fexofenadine—Body temperature increased—Temozolomide—malignant glioma	0.00723	0.0102	CcSEcCtD
Fexofenadine—Hypersensitivity—Carmustine—malignant glioma	0.00698	0.00981	CcSEcCtD
Fexofenadine—Asthenia—Carmustine—malignant glioma	0.00679	0.00955	CcSEcCtD
Fexofenadine—Hypersensitivity—Temozolomide—malignant glioma	0.00674	0.00948	CcSEcCtD
Fexofenadine—Asthenia—Temozolomide—malignant glioma	0.00656	0.00923	CcSEcCtD
Fexofenadine—Diarrhoea—Carmustine—malignant glioma	0.00648	0.00911	CcSEcCtD
Fexofenadine—Pruritus—Temozolomide—malignant glioma	0.00647	0.0091	CcSEcCtD
Fexofenadine—Dizziness—Carmustine—malignant glioma	0.00626	0.0088	CcSEcCtD
Fexofenadine—Diarrhoea—Temozolomide—malignant glioma	0.00626	0.0088	CcSEcCtD
Fexofenadine—Dizziness—Temozolomide—malignant glioma	0.00605	0.00851	CcSEcCtD
Fexofenadine—Vomiting—Carmustine—malignant glioma	0.00602	0.00846	CcSEcCtD
Fexofenadine—Rash—Carmustine—malignant glioma	0.00597	0.00839	CcSEcCtD
Fexofenadine—Dermatitis—Carmustine—malignant glioma	0.00596	0.00838	CcSEcCtD
Fexofenadine—Headache—Carmustine—malignant glioma	0.00593	0.00834	CcSEcCtD
Fexofenadine—Vomiting—Temozolomide—malignant glioma	0.00582	0.00818	CcSEcCtD
Fexofenadine—Rash—Temozolomide—malignant glioma	0.00577	0.00811	CcSEcCtD
Fexofenadine—Dermatitis—Temozolomide—malignant glioma	0.00576	0.0081	CcSEcCtD
Fexofenadine—Headache—Temozolomide—malignant glioma	0.00573	0.00806	CcSEcCtD
Fexofenadine—Nausea—Carmustine—malignant glioma	0.00562	0.00791	CcSEcCtD
Fexofenadine—Methadone—CYP2B6—malignant glioma	0.00558	0.266	CrCbGaD
Fexofenadine—Nausea—Temozolomide—malignant glioma	0.00543	0.00764	CcSEcCtD
Fexofenadine—SLCO1B3—Metabolism—PTGS1—malignant glioma	0.00031	0.00116	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CCR4—malignant glioma	0.000309	0.00115	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000309	0.00115	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000303	0.00113	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—TNF—malignant glioma	0.000294	0.0011	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000293	0.00109	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—IDH1—malignant glioma	0.00029	0.00108	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—BCHE—malignant glioma	0.000289	0.00108	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—SLC5A5—malignant glioma	0.000285	0.00106	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000283	0.00106	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—SPHK1—malignant glioma	0.000281	0.00105	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00028	0.00105	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000276	0.00103	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYP2C18—malignant glioma	0.000275	0.00103	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.00027	0.00101	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000267	0.000997	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000267	0.000996	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MDK—malignant glioma	0.000264	0.000984	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000262	0.00098	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—COX8A—malignant glioma	0.000262	0.000979	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GSTT1—malignant glioma	0.00026	0.000972	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000259	0.000969	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CXCR3—malignant glioma	0.000253	0.000945	CbGpPWpGaD
Fexofenadine—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000253	0.000945	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DTX1—malignant glioma	0.000251	0.000939	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—COX8A—malignant glioma	0.000247	0.000923	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTGS1—malignant glioma	0.000244	0.000911	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000243	0.000907	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—F2—malignant glioma	0.000241	0.000899	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000238	0.000891	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000236	0.000883	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000233	0.00087	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—BDKRB2—malignant glioma	0.000231	0.000864	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CXCR3—malignant glioma	0.00023	0.000858	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GSTP1—malignant glioma	0.00023	0.000857	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000228	0.000852	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—BCHE—malignant glioma	0.000227	0.000847	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000226	0.000846	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—SLC5A5—malignant glioma	0.000224	0.000836	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CAT—malignant glioma	0.000223	0.000834	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000223	0.000833	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ASMT—malignant glioma	0.000223	0.000833	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000223	0.000832	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000223	0.000832	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTT1—malignant glioma	0.000223	0.000831	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000222	0.00083	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.00022	0.000822	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00022	0.000821	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000215	0.000803	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—PIK3CA—malignant glioma	0.000213	0.000797	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000212	0.000791	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—NCOR1—malignant glioma	0.000211	0.000788	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—KNG1—malignant glioma	0.000211	0.000786	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—BDKRB2—malignant glioma	0.00021	0.000785	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ASMT—malignant glioma	0.00021	0.000785	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.00021	0.000784	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—BCAN—malignant glioma	0.00021	0.000783	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTGS1—malignant glioma	0.000209	0.000779	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.000208	0.000776	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000208	0.000776	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000206	0.00077	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000205	0.000764	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SUFU—malignant glioma	0.0002	0.000746	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.0002	0.000746	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—BCAN—malignant glioma	0.000198	0.000738	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HEY2—malignant glioma	0.000197	0.000737	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000195	0.000727	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—BCHE—malignant glioma	0.000194	0.000724	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GFAP—malignant glioma	0.000193	0.00072	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—SLC5A5—malignant glioma	0.000191	0.000715	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—KNG1—malignant glioma	0.000191	0.000714	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.000191	0.000713	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000188	0.000701	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SPHK1—malignant glioma	0.000186	0.000696	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000183	0.000683	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HEY1—malignant glioma	0.000183	0.000682	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCR4—malignant glioma	0.000183	0.000682	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000181	0.000676	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GSTP1—malignant glioma	0.00018	0.000674	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000179	0.00067	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HIST1H3B—malignant glioma	0.000177	0.000663	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000176	0.000659	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CAT—malignant glioma	0.000176	0.000655	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CAV1—malignant glioma	0.000172	0.000642	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CXCL8—malignant glioma	0.00017	0.000634	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MMP3—malignant glioma	0.000169	0.000633	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000169	0.000633	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—IDH2—malignant glioma	0.000169	0.000631	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—NCOR1—malignant glioma	0.000166	0.000619	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000164	0.000614	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JAG2—malignant glioma	0.000162	0.000605	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—IDH2—malignant glioma	0.000159	0.000595	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2B6—malignant glioma	0.000159	0.000593	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CG—malignant glioma	0.000157	0.000585	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000156	0.000584	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000156	0.000582	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTP1—malignant glioma	0.000154	0.000576	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000152	0.000569	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PPARG—malignant glioma	0.000151	0.000565	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CAT—malignant glioma	0.00015	0.00056	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP2B6—malignant glioma	0.00015	0.000559	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—IDH1—malignant glioma	0.000145	0.000543	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000145	0.000542	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000144	0.000538	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—NCOR1—malignant glioma	0.000142	0.000529	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SPHK1—malignant glioma	0.000141	0.000525	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2C18—malignant glioma	0.000138	0.000514	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CD—malignant glioma	0.000138	0.000514	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—H3F3A—malignant glioma	0.000137	0.000512	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—IDH1—malignant glioma	0.000137	0.000511	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—F2—malignant glioma	0.000136	0.000508	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCR3—malignant glioma	0.000136	0.000507	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CAV1—malignant glioma	0.000135	0.000505	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SPHK1—malignant glioma	0.000132	0.000495	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000132	0.000494	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NTRK2—malignant glioma	0.000132	0.000493	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—YWHAE—malignant glioma	0.000132	0.000493	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FLT1—malignant glioma	0.000131	0.000491	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DUSP6—malignant glioma	0.000131	0.000489	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CG—malignant glioma	0.00013	0.000486	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP2C18—malignant glioma	0.00013	0.000485	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JAG1—malignant glioma	0.000129	0.000483	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000129	0.000482	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOTCH3—malignant glioma	0.000129	0.000481	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000128	0.000478	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FBXW7—malignant glioma	0.000127	0.000473	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—BDKRB2—malignant glioma	0.000124	0.000464	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—F2—malignant glioma	0.000124	0.000462	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CG—malignant glioma	0.000123	0.00046	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CB—malignant glioma	0.00012	0.000448	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AKT2—malignant glioma	0.000119	0.000445	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTGS2—malignant glioma	0.000119	0.000444	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PPARG—malignant glioma	0.000119	0.000444	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CG—malignant glioma	0.000118	0.000442	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PTPN11—malignant glioma	0.000116	0.000434	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CAV1—malignant glioma	0.000116	0.000431	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOTCH2—malignant glioma	0.000115	0.000431	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000115	0.000428	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KNG1—malignant glioma	0.000113	0.000422	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTT1—malignant glioma	0.000111	0.000416	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.00011	0.000412	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT2—malignant glioma	0.000108	0.000404	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CD—malignant glioma	0.000108	0.000404	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000108	0.000404	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NTRK1—malignant glioma	0.000108	0.000402	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CG—malignant glioma	0.000105	0.000393	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTT1—malignant glioma	0.000105	0.000392	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTGS1—malignant glioma	0.000104	0.00039	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CD—malignant glioma	0.000104	0.000388	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTEN—malignant glioma	0.000104	0.000387	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPARG—malignant glioma	0.000102	0.000379	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP3—malignant glioma	0.0001	0.000374	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CB—malignant glioma	9.98e-05	0.000373	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN2B—malignant glioma	9.92e-05	0.000371	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTGS1—malignant glioma	9.84e-05	0.000367	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—BCHE—malignant glioma	9.7e-05	0.000362	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTK2—malignant glioma	9.63e-05	0.00036	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CXCL8—malignant glioma	9.59e-05	0.000358	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC5A5—malignant glioma	9.59e-05	0.000358	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HES1—malignant glioma	9.46e-05	0.000353	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CB—malignant glioma	9.43e-05	0.000352	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NCOR1—malignant glioma	9.41e-05	0.000351	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTGS2—malignant glioma	9.34e-05	0.000349	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—RAF1—malignant glioma	9.28e-05	0.000347	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CD—malignant glioma	9.25e-05	0.000346	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—IL2—malignant glioma	9.17e-05	0.000342	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—BCHE—malignant glioma	9.14e-05	0.000341	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CB—malignant glioma	9.06e-05	0.000338	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC5A5—malignant glioma	9.03e-05	0.000337	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PDGFRA—malignant glioma	9.01e-05	0.000337	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	8.83e-05	0.00033	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SPP1—malignant glioma	8.75e-05	0.000327	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CXCL8—malignant glioma	8.71e-05	0.000325	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL2—malignant glioma	8.32e-05	0.000311	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TERT—malignant glioma	8.29e-05	0.00031	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTEN—malignant glioma	8.15e-05	0.000304	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PDGFB—malignant glioma	8.09e-05	0.000302	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CB—malignant glioma	8.06e-05	0.000301	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGFR1—malignant glioma	8.05e-05	0.000301	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTGS2—malignant glioma	7.99e-05	0.000298	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HIF1A—malignant glioma	7.93e-05	0.000296	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTP1—malignant glioma	7.72e-05	0.000288	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CAV1—malignant glioma	7.67e-05	0.000286	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KDR—malignant glioma	7.59e-05	0.000283	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CAT—malignant glioma	7.51e-05	0.000281	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CA—malignant glioma	7.32e-05	0.000273	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—F2—malignant glioma	7.3e-05	0.000273	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FN1—malignant glioma	7.3e-05	0.000273	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTP1—malignant glioma	7.28e-05	0.000272	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—BAD—malignant glioma	7.21e-05	0.000269	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOTCH1—malignant glioma	7.15e-05	0.000267	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NCOR1—malignant glioma	7.1e-05	0.000265	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CAT—malignant glioma	7.08e-05	0.000264	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CD80—malignant glioma	7e-05	0.000261	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APC—malignant glioma	6.99e-05	0.000261	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CG—malignant glioma	6.99e-05	0.000261	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTEN—malignant glioma	6.97e-05	0.00026	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGF—malignant glioma	6.91e-05	0.000258	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTPN11—malignant glioma	6.86e-05	0.000256	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NCOR1—malignant glioma	6.69e-05	0.00025	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—BRAF—malignant glioma	6.57e-05	0.000245	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT2—malignant glioma	6.39e-05	0.000239	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—EGFR—malignant glioma	6.37e-05	0.000238	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CD—malignant glioma	6.14e-05	0.000229	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	6.08e-05	0.000227	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—KRAS—malignant glioma	6.01e-05	0.000225	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—AKT1—malignant glioma	5.98e-05	0.000223	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF2—malignant glioma	5.88e-05	0.00022	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CAV1—malignant glioma	5.78e-05	0.000216	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CA—malignant glioma	5.75e-05	0.000215	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	5.53e-05	0.000206	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MDM2—malignant glioma	5.5e-05	0.000206	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RAF1—malignant glioma	5.48e-05	0.000205	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CAV1—malignant glioma	5.45e-05	0.000204	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ERBB2—malignant glioma	5.43e-05	0.000203	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	5.35e-05	0.0002	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CG—malignant glioma	5.27e-05	0.000197	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL8—malignant glioma	5.15e-05	0.000192	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPARG—malignant glioma	5.08e-05	0.00019	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	4.97e-05	0.000186	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.96e-05	0.000185	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CASP3—malignant glioma	4.92e-05	0.000184	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL2—malignant glioma	4.92e-05	0.000184	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CA—malignant glioma	4.92e-05	0.000184	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPARG—malignant glioma	4.79e-05	0.000179	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AKT1—malignant glioma	4.7e-05	0.000175	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP9—malignant glioma	4.65e-05	0.000174	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CD—malignant glioma	4.63e-05	0.000173	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTEN—malignant glioma	4.63e-05	0.000173	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT1—malignant glioma	4.51e-05	0.000169	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.36e-05	0.000163	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFA—malignant glioma	4.18e-05	0.000156	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT3—malignant glioma	4.14e-05	0.000155	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CB—malignant glioma	4.04e-05	0.000151	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AKT1—malignant glioma	4.02e-05	0.00015	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTGS2—malignant glioma	4e-05	0.000149	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MYC—malignant glioma	3.84e-05	0.000144	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.8e-05	0.000142	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTGS2—malignant glioma	3.77e-05	0.000141	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGFR—malignant glioma	3.76e-05	0.00014	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KRAS—malignant glioma	3.55e-05	0.000133	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTEN—malignant glioma	3.49e-05	0.00013	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTEN—malignant glioma	3.29e-05	0.000123	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	3.26e-05	0.000122	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TP53—malignant glioma	3.16e-05	0.000118	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT1—malignant glioma	2.67e-05	9.96e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CA—malignant glioma	2.46e-05	9.19e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.32e-05	8.66e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AKT1—malignant glioma	2.01e-05	7.51e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AKT1—malignant glioma	1.89e-05	7.07e-05	CbGpPWpGaD
